Collaborative Drug Discovery

Collaborative Drug Discovery, Inc. (commonly shortened to CDD) is an American software company that builds and sells cloud-based laboratory informatics for drug discovery research. Its flagship product, CDD Vault, is a scientific data management system and electronic lab notebook (ELN) that stores both biology and chemistry data in a single flexible system, lets research teams collaborate in real time through any web browser, and helps organizations safeguard intellectual property while structuring data for AI and machine-learning applications. The company markets itself as "Trusted Lab Informatics Software by 100s of Top Organizations" and emphasizes rapid time to value, noting that new users can become proficient after about 90 minutes of guided onboarding. CDD was established in 2004, when founder and CEO Barry Bunin was an entrepreneur in residence at Eli Lilly & Co.; the company spun out of Lilly that same year, with the University of California, San Francisco signing up as its first customer. Its mission, as stated on its website, is to provide an unparalleled software experience for humanitarian and commercial collaborative research and discovery. True to its name, CDD positions CDD Vault as a collaboration platform used by hundreds of organizations and thousands of scientists globally. Beyond the core CDD Vault product, CDD offers professional services that design, adapt, and evolve the platform for scientific teams. These include data migration from legacy ELNs and LIMS into a collaborative cloud environment, custom integrations connecting CDD Vault to dashboards, analysis pipelines, AI agents, third-party software, and instruments, custom feature development, and dedicated technical resources. The company also provides a documented API for command-line access and custom scripts, and its support team consists of lab-trained scientists. CDD's history includes several notable milestones: a 2008 grant from the Bill & Melinda Gates Foundation to accelerate tuberculosis drug discovery; adoption of CDD Vault by the NIH Neuroscience Blueprint Network in 2012; the one-millionth customer login in 2019; the launch of PharmaKB (The Pharma KnowledgeBase) in 2021; support for biologics registration in 2022; and the rollout of AI, Automation, Curves, and Inventory (Samples) modules in 2024. The company remains privately held and continues to expand its platform and user base.

Collaborative Drug Discovery was established in 2004, when founder and CEO Barry Bunin was an entrepreneur in residence at Eli Lilly & Co. The company spun out of Lilly that year, and the University of California, San Francisco signed up as its first customer. Its flagship product, CDD Vault, was designed to address the problem of inefficient data management in biological and chemical research. In 2008, CDD was awarded a grant from the Bill & Melinda Gates Foundation to accelerate tuberculosis drug discovery. In 2012, the NIH adopted CDD Vault for the Neuroscience Blueprint Network. In 2019, CDD Vault celebrated its one-millionth customer login. In 2021, CDD launched PharmaKB (The Pharma KnowledgeBase). In 2022, CDD Vault rolled out support for biologics registration. In 2024, CDD Vault rolled out AI, Automation, Curves, and Inventory (Samples) modules. Over the years, CDD has significantly expanded the capabilities of its platform as well as its user base. True to its name, CDD Vault is used by hundreds of organizations and thousands of scientists globally to collaborate more effectively. The company also offers professional services including data migration, integration, custom features, and dedicated resources, and provides a documented API for command-line access and custom scripts.

• 2024

  CDD Vault rolls out AI, Automation, Curves, and Inventory (Samples) modules.

• 2022

  CDD Vault rolls out support for biologics registration.

• 2021

  CDD launches PharmaKB (The Pharma KnowledgeBase).

• 2019

  CDD Vault celebrates its 1,000,000th customer login.

• 2012

  NIH adopts CDD Vault for the Neuroscience Blueprint Network.

• 2008

  CDD awarded a grant from the Bill & Melinda Gates Foundation to accelerate TB drug discovery.

• 2004

  CDD spun out of Eli Lilly; UCSF signs up as first customer.

Cloud-based collaborative scientific data management and ELN software for drug discovery, emphasizing ease of use, rapid time to value, and support from lab-trained scientists.

• CDD Vault

  Cloud-based scientific data management system and ELN for drug discovery, storing biology and chemistry data in one flexible system.

• PharmaKB

  The Pharma KnowledgeBase, launched in 2021.

1. 1Scientific Data Management System & ELN Software - CDD Vaultcollaborativedrug.com
2. 2About Us | CDD Vaultcollaborativedrug.com
3. 3CDD Vault: Servicescollaborativedrug.com